A variety of GLP-1 drugs that were developed to treat Type 2 diabetes, including Novo Nordisk’s Ozempic, have secured label ...

If Buffett is unloading some stocks, it pays to take a closer look at their fundamentals. Here's a quick look at the stocks ...

CoreWeave stock was rising sharply Thursday after a Wall Street analyst upgraded the artificial-intelligence cloud vendor.